1. Home
  2. YDKG vs CLGN Comparison

YDKG vs CLGN Comparison

Compare YDKG & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

YDKG

Yueda Digital Holding Class A Ordinary Share

N/A

Current Price

$0.87

Market Cap

5.3M

ML Signal

N/A

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$3.47

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YDKG
CLGN
Founded
2005
2004
Country
China
Israel
Employees
N/A
N/A
Industry
Advertising
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3M
5.2M
IPO Year
2007
2015

Fundamental Metrics

Financial Performance
Metric
YDKG
CLGN
Price
$0.87
$3.47
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$11.00
AVG Volume (30 Days)
11.8K
9.8M
Earning Date
05-12-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$240.45
Revenue Next Year
N/A
$38.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$0.26
52 Week High
$3.90
$3.91

Technical Indicators

Market Signals
Indicator
YDKG
CLGN
Relative Strength Index (RSI) 36.67 91.98
Support Level $0.81 $0.34
Resistance Level $1.03 N/A
Average True Range (ATR) 0.07 0.20
MACD -0.02 0.39
Stochastic Oscillator 20.34 89.30

Price Performance

Historical Comparison
YDKG
CLGN

About YDKG Yueda Digital Holding Class A Ordinary Share

Yueda Digital Holding is a Web3 and digital company with a focus on the long-term accumulation of mainstream cryptocurrencies. The business activities of the company include active treasury management of mainstream digital assets, exploration of compliant, risk-managed yield opportunities, such as staking, on-chain liquidity provision, and other conservative market activities, selective investments and partnerships in Web3 infrastructure and applications, and advisory services for enterprises entering the digital-asset economy.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: